Pulished : October, 2018
ID: 110
Region: Global
Share on

The Infectious Disease Therapeutics Market Is Predicted To Reach USD 154.18 Billion By 2023 With A CAGR Of 7.96 % According To Market Data Forecast Report.

Pulished: October, 2018
ID: 110
Share on

The Infectious Disease Therapeutics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Infectious Disease Therapeutics Market is estimated to be 105.13 USD Million in 2018 and predicted to rise to 154.18 USD Million by the end of 2023 with a CAGR of 7.96 %. The Market is categorized based on the mode of treatment into drugs and vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on target organism into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type into bacterial, viral, fungal, parasitic and others. Based on distribution channels the market is segmented into Hospitals, clinics and others. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The market is primarily driven by factors such as increasing occurrence of infectious diseases, growing use of direct acting anti-viral, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. generic erosion, Patent expiration of infectious disease drugs are the restraints that are hindering the growth of the Infectious disease therapeutics market.

Based on Mode of treatment, drugs are predicted to hold the largest share in the market owing to wide applications. Based on the target organism, Antibacterial is predicted to account the highest share in the market. North America is projected to account the highest share in the market due to the increasing incidence of infectious diseases in this region that leads to high demand for Anti-infective drugs, which thereby, boosting the demand for this Market. Asia-Pacific is expected to show the highest CAGR during the forecast period due to increasing demand as a consequence of growing population base with high unmet medical needs.

Major players that are influencing Global Infectious disease therapeutics Market are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-infectious-Disease-therapeutics-market-1320/” and checkout our recent reports in the Therapeutics category at “http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.